Calcipotriol/hydrocortisone

Drug Profile

Calcipotriol/hydrocortisone

Alternative Names: LEO-80190

Latest Information Update: 21 Dec 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator LEO Pharma
  • Class Anti-inflammatories; Antipsoriatics; Dihydroxycholecalciferols; Glucocorticoids; Pregnenediones; Small molecules; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists; Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Psoriasis

Most Recent Events

  • 23 Sep 2009 LEO 80190 is no longer licensed to Warner Chilcott
  • 15 Sep 2005 Warner Chilcott has licensed the full portfolio of LEO Pharma's present and future psoriasis therapies in USA
  • 26 May 2005 Phase-II clinical trials in Psoriasis in Denmark (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top